ClinConnect ClinConnect Logo
Search / Trial NCT05801653

Health Effects of Oat Bioactives (Betaglucan) in Human

Launched by LUND UNIVERSITY · Mar 24, 2023

Trial Information

Current as of June 18, 2025

Completed

Keywords

ClinConnect Summary

The overall goal is to increase the knowledge which can be used for the development of food products with anti-diabetic properties, with the purpose to facilitate healthier food choices for people. More specifically the primary purpose of this project is to evaluate effects in healthy humans on cardiometabolic test markers of oat and oat based product. The new knowledge will form a base for the development of oat based food products with added health values.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Healthy adults BMI 18.5 - 28 Kg/m2 Non smokers Consuming a non-vegetarian diet that follows the Nordic diet recommendation.
  • Exclusion Criteria:
  • - Fasting blood glucose concentration \>6.1 mmol/l Known cardio-metabolic disease (e.g. diabetes, hypertension, metabolic syndrome).
  • Gastro-intestinal disorders such as IBS (irritable bowel syndrome) that can interfere with the study results, food allergies.
  • No antibiotics or probiotics should have been consumed within 4 weeks prior to and during the study.

About Lund University

Lund University, a prestigious research institution in Sweden, is renowned for its commitment to advancing scientific knowledge and innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at addressing critical health challenges. Leveraging its state-of-the-art facilities and a diverse network of expert researchers, Lund University strives to translate research findings into effective therapeutic solutions, ultimately improving patient outcomes and enhancing public health. Through its dedication to ethical research practices and patient safety, Lund University plays a pivotal role in the global clinical research landscape.

Locations

Lund, Skane, Sweden

Patients applied

0 patients applied

Trial Officials

Anne Nilsson

Principal Investigator

Department of Food Technology, Engineering and Nutrition, Lund Univesity

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials